Send us Feedback

Endo Pharmaceuticals Holdings (ENDP)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
 
 
 
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Income Statement    (USD)
Annual | Quarterly
QUARTER ENDING 31-MAR
2012		 30-JUN
2012		 30-SEP
2012		 31-DEC
2012		 31-MAR
2013
Total Revenue 691M 785M 750M 801M 709M
Cost of Revenue 290M 212M 212M 224M 209M
Gross Profit 401M 573M 538M 577M 499M
Research & Development 88.7M 45.4M 49.0M 43.1M 41.6M
SG&A 254M 234M 293M 118M 236M
Amortization & Deprec 74.8M 82.3M 81.8M 83.3M 76.6M
Other Expenses 43.6M 134M -29.3M 1.04B 70.6M
Total Operating Expenses 462M 496M 394M 1.28B 425M
Operating Income -61.0M 77.3M 144M -704M 74.1M
Other Income -5.88M -7.35M -1.54M 691K 6.86M
EBIT -66.8M 69.9M 142M -704M 80.9M
Minority Interest 12.8M 12.6M 14.4M 12.5M 11.3M
Interest Expense 47.0M 46.1M 45.5M 44.4M 44.4M
Income Before Taxes -127M 11.2M 82.1M -761M 25.3M
Income Taxes -39.3M 1.78M 28.3M -44.3M 9.94M
Net Income from Continuing Ops -87.3M 9.46M 53.8M -716M 15.3M
Income - Discontinued Ops 0 0 0 0 0
Extraordinary Items 0 0 0 0 0
Effect of Accounting Changes 0 0 0 0 0
Other Items 0 0 0 0 0
Net Income -87.3M 9.46M 53.8M -716M 15.3M
Preferred Dividends 0 0 0 0 0
Net Income to Common -87.3M 9.46M 53.8M -716M 15.3M
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Data Sources:
Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki